Brokerages Anticipate Ligand Pharmaceuticals (LGND) Will Post Earnings of $1.28 Per Share

Joanna Estrada
April 23, 2018

About 153,051 shares traded. Shares for $401,063 were sold by KOZARICH JOHN W. On Monday, February 26 Davis Todd C sold $2.62 million worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 17,170 shs.

Sander Gerber decreased its stake in Horizon Pharma Plc (HZNP) by 77.78% based on its latest 2017Q4 regulatory filing with the SEC. Cardinal Capital Management LLC CT raised its holdings in shares of Ligand Pharmaceuticals by 5.0% in the fourth quarter. The institutional investor held 762,944 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $104.47M, down from 798,100 at the end of the previous reported quarter. Suffolk Capital Management Llc who had been investing in Ligand Pharmaceuticals Incorpo for a number of months, seems to be bullish on the $3.54B market cap company.

The stock increased 0.36% or $0.07 during the last trading session, reaching $19.71. About 349,538 shares traded. It has underperformed by 2.64% the S&P500.

Investors sentiment decreased to 1.33 in Q4 2017. It has change of 0.44, from 2017Q3's 1.69. The insider Aryeh Jason sold $1.32 million. 256.03 million shares or 0.61% more from 254.48 million shares in 2017Q3 were reported. Ligand Pharmaceuticals posted earnings per share of $0.57 in the same quarter last year, which suggests a positive year over year growth rate of 124.6%. Ubs Asset Americas holds 0.01% or 114,502 shs in its capital. Guardian Life Insurance Company Of America holds 0.03% of its portfolio in Equinix, Inc. Strs Ohio reported 0% stake. For a total of 432,277 shares it reduced its holding in Mgp Ingredients Inc New (NASDAQ:MGPI) by 89,328 shares in the quarter, and has cut its stake in Pacwest Bancorp Del (NASDAQ:PACW). Tiaa Cref Mgmt stated it has 56,185 shares or 0.01% of all its holdings. Granite Ltd stated it has 84,598 shares. 3,284 were accumulated by Alpine Woods Invsts Limited Liability Company. Comerica Bankshares owns 29,400 shares for 0.03% of their portfolio. Point72 Asset LP holds 0.06% of its portfolio in Equinix, Inc. New York State Teachers Retirement Systems has 0% invested in Team, Inc. Qs Limited Liability Com owns 503 shs. Healthinvest Partners Ab owns 20,200 shares or 5.84% of their USA portfolio. Bnp Paribas Arbitrage Sa invested in 0% or 8,622 shs.

Hudson Bay Capital Management Lp, which manages about $4.18 billion and $4.65 billion US Long portfolio, upped its stake in Time Warner Inc (NYSE:TWX) by 30,769 shares to 230,769 shares, valued at $21.11M in 2017Q4, according to the filing. LGND has also 39,775 shares volume.

In total 5 analysts cover Ligand Pharmaceuticals (NASDAQ:LGND). They expect $1.11 earnings per share, up 184.62% or $0.72 from last year's $0.39 per share. LGND's profit would be $23.54M giving it 37.61 P/E if the $1.11 EPS is correct.

Among 11 analysts covering UDG Healthcare PLC (LON:UDG), 6 have Buy rating, 1 Sell and 4 Hold. Horizon Pharma had 62 analyst reports since September 9, 2015 according to SRatingsIntel. On Friday, December 8 the stock rating was initiated by Citigroup with "Hold". Cowen & Co maintained Aircastle Limited (NYSE:AYR) rating on Wednesday, November 4. The stock has "Outperform" rating by BMO Capital Markets on Wednesday, June 29. H.C. Wainwright has "Buy" rating and $170 target. The stock rating was maintained by Craig Hallum with "Buy" on Thursday, February 22. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has "Buy" rating given on Monday, October 31 by Mizuho. In Thursday, February 22 report Stephens maintained the stock with "Buy" rating. The firm has "Hold" rating by Mizuho given on Monday, August 28.

Investors sentiment decreased to 1.25 in Q4 2017. Its down 3.51% from 1.41 million shares previously. The ratio is negative due to LGND positioning: 21 sold and 86 reduced. 31 funds acquired holdings and 103 increased holdings. 967,527 were reported by State Street. Following the transaction, the chief executive officer now directly owns 111,700 shares in the company, valued at approximately $18,430,500. Willingdon Wealth Management holds 15,075 shares. 52,100 were reported by Gotham Asset Limited Liability Corp. Zacks Investment Research raised shares of Ligand Pharmaceuticals from a "hold" rating to a "buy" rating and set a $171.00 price target on the stock in a report on Wednesday, February 28th. Court Place Advsrs Limited Liability has invested 1.13% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Meridian Invest Counsel holds 0.24% or 3,145 shares. Goodbody maintained the stock with "Buy" rating in Thursday, August 4 report. BlackRock Inc. now owns 2,996,960 shares of the biotechnology company's stock valued at $410,374,000 after acquiring an additional 51,259 shares in the last quarter. Us Bancshares De owns 0% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 10,978 shares. The positive are 80%. Also, the number of hedge funds holding Ligand Pharmaceuticals Inc in top ten stock positions decreased from 10 to 7 for a decrease of 3. The company was maintained on Thursday, September 3 by Roth Capital. Silicom Ltd. (NASDAQ:SILC) has declined 24.78% since April 22, 2017 and is downtrending. The firm has "Buy" rating given on Monday, September 21 by Roth Capital. One equities research analyst has rated the stock with a sell rating, six have issued a buy rating and one has given a strong buy rating to the stock. Roth Capital started coverage on Ligand Pharmaceuticals in a research report on Monday, February 27th. The firm has "Buy" rating given on Wednesday, March 7 by Craig Hallum.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article